Approvals/TGA/CEFTAZIDIME KABI ceftazidime (as pentahydrate) 2 g powder for injection vial

Approved

STANDARD

CEFTAZIDIME KABI ceftazidime (as pentahydrate) 2 g powder for injection vial

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: caccd5c8bb46649e
Product Name: CEFTAZIDIME KABI ceftazidime (as pentahydrate) 2 g powder for injection vial
Artg Id: 223569
Artg Name: CEFTAZIDIME KABI ceftazidime (as pentahydrate) 2 g powder for injection vial
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2015-07-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4bfa2a067ad6f8a28cb3798b9986c2ee.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1bdc9c2eb861e10c65e87436a33f46ad.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

caccd5c8bb46649e

Type

Standard